Literature DB >> 17943163

MT1-MMP as a downstream target of BCR-ABL/ABL interactor 1 signaling: polarized distribution and involvement in BCR-ABL-stimulated leukemic cell migration.

X Sun, Y Li, W Yu, B Wang, Y Tao, Z Dai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17943163      PMCID： PMC2430881          DOI： 10.1038/sj.leu.2404990

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

Review 1.  MT1-MMP: a potent modifier of pericellular microenvironment.

Authors:  Yoshifumi Itoh; Motoharu Seiki
Journal:  J Cell Physiol       Date:  2006-01       Impact factor: 6.384

Review 2.  The matrix corroded: podosomes and invadopodia in extracellular matrix degradation.

Authors:  Stefan Linder
Journal:  Trends Cell Biol       Date:  2007-02-01       Impact factor: 20.808

3.  Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium.

Authors:  Salomón Matías-Román; Beatriz G Gálvez; Laura Genís; María Yáñez-Mó; Gonzalo de la Rosa; Paloma Sánchez-Mateos; Francisco Sánchez-Madrid; Alicia G Arroyo
Journal:  Blood       Date:  2005-01-21       Impact factor: 22.113

4.  Membrane type 1-matrix metalloproteinase is involved in the migration of human monocyte-derived dendritic cells.

Authors:  Mei-Xiang Yang; Xun Qu; Bei-Hua Kong; Queenie L K Lam; Qian-Qian Shao; Bi-Ping Deng; King-Hung Ko; Liwei Lu
Journal:  Immunol Cell Biol       Date:  2006-09-05       Impact factor: 5.126

5.  Bcr-Abl induces abnormal cytoskeleton remodeling, beta1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathway.

Authors:  Yingzhu Li; Nancy Clough; Xiaolin Sun; Weidong Yu; Brian L Abbott; Christopher J Hogan; Zonghan Dai
Journal:  J Cell Sci       Date:  2007-03-27       Impact factor: 5.285

Review 6.  Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization.

Authors:  W T Chen; J Y Wang
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

7.  Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.

Authors:  S Cowell; V Knäuper; M L Stewart; M P D'Ortho; H Stanton; R M Hembry; C López-Otín; J J Reynolds; G Murphy
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

8.  Membrane-type 1-matrix metalloproteinase regulates intracellular adhesion molecule-1 (ICAM-1)-mediated monocyte transmigration.

Authors:  Srinivas D Sithu; William R English; Paul Olson; Davia Krubasik; Andrew H Baker; Gillian Murphy; Stanley E D'Souza
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157
  8 in total
  11 in total

1.  Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis.

Authors:  Anna Chorzalska; John Morgan; Nagib Ahsan; Diana O Treaba; Adam J Olszewski; Max Petersen; Nathan Kingston; Yan Cheng; Kara Lombardo; Christoph Schorl; Xiaoqing Yu; Roberta Zini; Annalisa Pacilli; Alexander Tepper; Jillian Coburn; Anita Hryniewicz-Jankowska; Ting C Zhao; Elena Oancea; John L Reagan; Olin Liang; Leszek Kotula; Peter J Quesenberry; Philip A Gruppuso; Rossella Manfredini; Alessandro Maria Vannucchi; Patrycja M Dubielecka
Journal:  Blood       Date:  2018-09-13       Impact factor: 22.113

2.  CDK1-mediated phosphorylation of Abi1 attenuates Bcr-Abl-induced F-actin assembly and tyrosine phosphorylation of WAVE complex during mitosis.

Authors:  Chunmei Zhuang; Hongxing Tang; Sharmila Dissanaike; Everardo Cobos; Yunxia Tao; Zonghan Dai
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

3.  The anti-invasive activity of synthetic alkaloid ethoxyfagaronine on L1210 leukemia cells is mediated by down-regulation of plasminogen activators and MT1-MMP expression and activity.

Authors:  Jérôme Devy; Farid Ouchani; Christelle Oudot; Jean Jacques Helesbeux; Enguerran Vanquelef; Stéphanie Salesse; Fanja Rabenoelina; Siana Al-Khara; Isabelle Letinois; Olivier Duval; Laurent Martiny; Emmanuelle Charpentier
Journal:  Invest New Drugs       Date:  2010-03-28       Impact factor: 3.850

Review 4.  Structure and dynamic regulation of Abl kinases.

Authors:  Shoghag Panjarian; Roxana E Iacob; Shugui Chen; John R Engen; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2013-01-11       Impact factor: 5.157

5.  The roles and prognostic significance of ABI1-TSV-11 expression in patients with left-sided colorectal cancer.

Authors:  Yu Zhang; Zhaohui Zhong; Mei Li; Jingyi Chen; Tingru Lin; Jie Sun; Di Wang; Qing Mu; Huiting Su; Na Wu; Aiyu Liu; Yimeng Yu; Menglei Zhang; Yulan Liu; Jingzhu Guo; Weidong Yu
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

6.  Functional mechanisms and roles of adaptor proteins in abl-regulated cytoskeletal actin dynamics.

Authors:  Mizuho Sato; Masahiro Maruoka; Tatsuo Takeya
Journal:  J Signal Transduct       Date:  2012-05-17

7.  The research on the immuno-modulatory defect of mesenchymal stem cell from Chronic Myeloid Leukemia patients.

Authors:  Zhu Xishan; An Guangyu; Song Yuguang; Zhang Hongmei
Journal:  J Exp Clin Cancer Res       Date:  2011-05-02

8.  Epigenetic regulation of cathepsin L expression in chronic myeloid leukaemia.

Authors:  Misti Samaiya; Sameer Bakhshi; Abhay A Shukla; Lalit Kumar; Shyam S Chauhan
Journal:  J Cell Mol Med       Date:  2011-10       Impact factor: 5.310

9.  Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo.

Authors:  Weidong Yu; Xiaolin Sun; Nancy Clough; Everardo Cobos; Yunxia Tao; Zonghan Dai
Journal:  Carcinogenesis       Date:  2008-05-02       Impact factor: 4.944

10.  CRISPR/CAS9-mediated knockout of Abi1 inhibits p185Bcr-Abl-induced leukemogenesis and signal transduction to ERK and PI3K/Akt pathways.

Authors:  James Faulkner; Peixin Jiang; Delaney Farris; Ryan Walker; Zonghan Dai
Journal:  J Hematol Oncol       Date:  2020-04-10       Impact factor: 23.168
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.